Pharming Group N.V. (PHAR) Misses Q1 EPS by 1c

Pharming Group N.V. (NASDAQ: PHAR) reported Q1 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $79.09 million versus the consensus estimate of $64 million.

For earnings history and earnings-related data on Pharming Group N.V. (PHAR) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Commercial National Financial Corporation (CEFC) Declares $0.15 Quarterly Dividend; 3.8% Yield